INDUCTION COMBINATION THERAPY WITH GUSELKUMAB AND GOLIMUMAB FOLLOWED BY GUSELKUMAB MONOTHERAPY MAINTENANCE: RESULTS OF THE PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PROOF-OF-CONCEPT VEGA STUDY

Julian Panés  ¹     Bruce E. Sands  ²     William Sandborn  ³     Matthew Germinaro  ⁴     Marion Vetter  ⁴     Shihong Sheng  ⁴     Jewel Johanns  ⁴     Brian G. Feagan  ^5    
1 Hospital Clínic Barcelona, Barcelona, Spain
² Icahn School of Medicine at Mount Sinai, New York, United States
³ University of California San Diego, San Diego, United States
⁴ Janssen Research & Development, LLC, Spring House
⁵ The University of Western Ontario, London, Canada

Topic
IBD, Nurses, Primary Care

Session
Clinical trials in ulcerative colitis I

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)